BioPlus Co. Ltd.

BioPlus Co. Ltd.

099430 · KQ · Healthcare / Medical Instruments & Supplies

3,000.00KRW-20.00 (-0.66%)

Price History

Full chart

Market Stats

Previous Close3,020.00
Open3,020.00
Day Range3,000.00 – 3,120.00
52-Week Range3,065.00 – 6,655.69
Volume126.58K
Market Cap229.85B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield1.96%
Beta0.59
50-Day Avg3,446.20
200-Day Avg4,671.90

About

Bio Plus Co., Ltd engages in the research and development, production, and sale of bio products in South Korea. It offers dermal fillers under the SkinPlus " Hyal, Bio+ Dew, HyalDew, DeneB Classic, Stilea, and 3-Senses brand names. The company also provides medical products, including InterBlock, an absorbable anti-adhesion barrier; Synofil, a synovial fluid replacement; and Blad-Care, a solution to temporarily improve cystitis symptoms. In addition, it offers mesotherapy products, such as skin rejuvenation products under the Kiara Reju name; Slim Slimmer, a lipolysis solution; LumiDew, a whitening solution; JuveniHill, an anti-wrinkle solution; and hair scalp care, hair treatment, hair nutrition solutions under the BelloHa and BellaChe names, as well as cosmetics comprising heparinoid essence, EGF ball, and skin care gel under the La Bella name. The company was founded in 2003 and is based in Seongnam-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOHyun-Kyu Jung
  • Employees161
  • HeadquartersSeongnam Woolim Lions Valley 2 cha A dong 1801 and 1802 ho, Seongnam-si, South Korea, Korea
  • Websitehttps://www.bioplus.co.kr

Leadership

  • Hyun-Kyu JungChief Executive Officer

Financials

Income Statement

Currency: KRW2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue11.04B17.02B24.37B37.42B56.72B65.04B66.41B90.90B
Growth (%)-+54.20%+43.16%+53.56%+51.58%+14.68%+2.10%+36.87%
Cost of Revenue4.38B5.82B7.80B13.77B22.91B25.47B23.77B30.29B
Gross Profit6.66B11.20B16.56B23.65B33.81B39.57B42.64B60.61B
Gross Margin60.33%65.83%67.98%63.19%59.60%60.84%64.21%66.68%
Operating Expense2.69B4.40B4.24B6.98B8.56B11.54B18.98B45.60B
Operating Income3.97B6.80B12.33B16.66B25.24B28.03B23.67B15.01B
Operating Margin36.00%39.96%50.59%44.53%44.51%43.10%35.64%16.51%
EBITDA----29.37B35.29B21.20B21.90B
EBITDA Margin----51.78%54.26%31.92%24.10%
Net Income2.33B5.62B9.70B10.67B21.14B25.58B14.15B15.00B
Net Income Margin21.08%33.04%39.82%28.52%37.27%39.33%21.31%16.50%
R&D--276.05M435.18M1.08B1.17B1.48B3.39B
R&D as % of Total Revenue--1.13%1.16%1.91%1.79%2.22%3.73%
Interest Expense0058.16M521.47M13.30M60.28M263.43M303.65M
Interest Expense % of Total Revenue0.00%0.00%0.24%1.39%0.02%0.09%0.40%0.33%

Balance Sheet

Currency: KRW2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets13.28B21.00B37.94B88.46B146.52B172.81B264.30B285.04B
Total Liabilities5.91B3.15B9.42B9.76B33.25B34.75B116.56B90.06B
Total Equity7.37B17.85B28.52B78.70B113.27B127.82B133.49B174.84B
Cash-17.44M17.76M19.11M20.65M46.00B38.67B21.11B
Total Debt-45.83M38.05M-----
Net Debt------16.51B38.23B

Cash Flow

Currency: KRW2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow3.15B4.96B10.04B13.35B13.36B16.04B22.29B14.74B
Investing Cash Flow-1.87B-5.41B-1.58B-22.63B-67.13B21.73B-84.36B-
Financing Cash Flow1.63B-126.32M4.83B34.04B30.66B-10.21B53.72B-
Capital Expenditure735.65M6.51B1.10B15.36B6.69B21.57B96.65B47.93B
Free Cash Flow-353.79M8.95B-2.01B6.67B-5.53B-74.36B-33.19B
Dividends Paid----0---
FCF to OCF-7.13%89.09%-15.02%49.89%-34.49%-333.59%-225.19%
Dividend Paid to FCF----0.00%---

Earnings

Report DateSep 30, 2021Mar 23, 2022May 15, 2022Aug 15, 2022Nov 13, 2022Feb 13, 2023Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate--------------------
EPS Actual-16.6656.6387.0095.5091.5097.77100.94124.2494.52112.3539.2595.8758.1053.85122.766.3952.75-34.53104.1333.18
Surprise--------------------
Timing-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours--------------

Key Statistics & Ratios

Market Cap229.85B
Enterprise Value238.47B
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.32
Price / Book1.13
Revenue (TTM)99.15B
Gross Profit (TTM)67.93B
EBITDA22.24B
Profit Margin13.96%
Operating Margin24.59%
Return on Equity10.65%
Return on Assets3.90%
Shares Outstanding61.54M
Shares Float43.16M
Beta0.59
Dividend Yield1.96%
Dividend Rate70.00
Payout Ratio45.00%

Dividends

20251×
70.00Dec 29, 2025
20241×
50.00Dec 27, 2024
20231×
70.00Dec 27, 2023
20221×
70.00Dec 28, 2022

Stock Splits

  • Nov 23, 20224:1